Hydroxocobalamin G.L. Pharma (Hydroxocobalamin Acetate)

Hydroxocobalamin provides vitamin B12 activity by being converted inside cells to the active coenzymes methylcobalamin and adenosylcobalamin. These coenzymes act as essential cofactors for methionine synthase and methylmalonyl‑CoA mutase, enzymes required for DNA synthesis, myelin formation, and red blood cell maturation.

The specific dose and dosing schedule of Hydroxocobalamin are determined by the prescribing healthcare professional based on the patient’s clinical condition, severity of deficiency, and response to therapy. Dosage may vary widely, and the prescriber will tailor the regimen to each individual case.

Safety data for Hydroxocobalamin during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss potential risks with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The sales team will then provide pricing, availability, shipping details (including cold‑chain if required), and necessary import documentation.

Hydroxocobalamin and cyanocobalamin are both vitamin B12 forms, but hydroxocobalamin has a longer plasma half‑life and higher tissue retention, making it preferable for long‑term maintenance therapy. Cyanocobalamin is often used for oral supplementation, whereas hydroxocobalamin is typically administered parenterally for rapid correction of deficiency.

Hydroxocobalamin should be stored refrigerated at 2‑8 °C, protected from light, and kept in its original container. It must not be frozen or shaken vigorously. If a temporary temperature excursion occurs, the product should be inspected for any visual changes before use.

Hydroxocobalamin is given by a healthcare professional via intramuscular or subcutaneous injection. The injection site is typically the deltoid, gluteal muscle, or thigh, depending on patient factors and clinical judgment. Proper aseptic technique and correct dosing are essential for safe administration.

The most serious risks include severe hypersensitivity reactions such as anaphylaxis, hypotension, and rare but severe skin reactions like Stevens‑Johnson syndrome. Patients should be monitored closely after injection for any signs of allergic response, and immediate medical attention should be sought if serious symptoms develop.

Hydroxocobalamin is contraindicated in individuals with a known hypersensitivity to hydroxocobalamin or any cobalamin preparations. Patients with severe renal impairment should use it only under strict medical supervision, and those with a history of severe allergic reactions to injectable vitamins should avoid it unless an alternative is unavailable.